Blumberg J M, Malhotra A, Wu X, Virk R K, Kveton J F, Michaelides E M
Department of Surgery, Section of Otolaryngology, Yale School of Medicine, 333 Cedar St, 06520-8042, New Haven, CT, USA.
Department of Diagnostic Radiology, Yale School of Medicine, Tompkins East 2, 333 Cedar St, 06520-8042, Box 208042, New Haven, CT, USA.
Clin Neuroradiol. 2017 Jun;27(2):163-168. doi: 10.1007/s00062-015-0461-4. Epub 2015 Sep 4.
This study is conducted to demonstrate that destructive lesions of the otic capsule by Langerhans cell histiocytosis (LCH) causing both radiographic and audiologic findings can be completely reversed with adequate treatment. Retrospective case review and analysis of clinical and imaging data were obtained as part of the diagnosis and treatment of patients with LCH of the temporal bone.
With Institutional Review Board (IRB) approval, cases of LCH involving the temporal bone were searched for within the institutional databases. Criteria for inclusion was histologic diagnosis of LCH and pretreatment computed tomography (CT) demonstrating temporal bone and/or otic capsule involvement and posttreatment follow-up CT/magnetic resonance imaging (MRI) scans obtained at least 6 months after starting treatment.
We report eight cases of LCH of the temporal bone with three demonstrating otic capsule involvement radiographically and/or clinically. Review of posttreatment imaging revealed all three patients had complete restoration of the bony labyrinthine architecture and near or complete restoration of their hearing.
Though LCH of the temporal bone is a common site within the spectrum of the disease, involvement of the otic capsule remains rare. Here, we report the largest series of otic capsule involvement by LCH and investigate whether both architecture and hearing are recovered with appropriate treatment. Lastly, restoration of the bony architecture of the labyrinth suggests the mechanism of LCH is demineralization and not ablative.
本研究旨在证明,朗格汉斯细胞组织细胞增多症(LCH)导致的耳囊破坏性病变,所引起的影像学和听力学表现,在经过充分治疗后可完全逆转。作为颞骨LCH患者诊断和治疗的一部分,我们对临床和影像数据进行了回顾性病例分析。
经机构审查委员会(IRB)批准,在机构数据库中搜索累及颞骨的LCH病例。纳入标准为LCH的组织学诊断,以及治疗前计算机断层扫描(CT)显示颞骨和/或耳囊受累,且在开始治疗至少6个月后获得治疗后随访CT/磁共振成像(MRI)扫描结果。
我们报告了8例颞骨LCH病例,其中3例在影像学和/或临床上显示耳囊受累。对治疗后影像的回顾显示,所有3例患者的骨迷路结构均完全恢复,听力接近或完全恢复。
尽管颞骨LCH是该疾病谱系中的常见部位,但耳囊受累仍然罕见。在此,我们报告了最大系列的LCH累及耳囊的病例,并研究了经过适当治疗后,骨迷路结构和听力是否均能恢复。最后,迷路骨结构的恢复表明LCH的机制是脱矿而非消融。